En 20 ans, la France est passée de la 5ème à la 9ème place mondiale en recherche biomédicale. Comment restaurer la compétitivité de la recherche française? Diagnostic et réponses dans mon article. https://t.co/ZyGN63hj3T #recherche#sante#reforme#Presidentielle2022
Manager Maryaline Catillon presented on the role of research and real-world data in hospital innovation and patient care at the AIA Life Designers conference in Lyon. https://t.co/TBEQwxRHOZ
Season's greetings from Analysis Group! We are a firm of many different people, backgrounds, and cultures. Our people speak more than 45 languages and have just as many ways to wish you a happy holiday season.
An Analysis Group team led by Mihran Yenikomshian, Lynn Huynh, Enrico Zanardo, and Rui Song studied the real-world effectiveness of a novel therapy on patients' need for blood transfusions. https://t.co/NONtlU1T2F
Today we announce a leadership transition. Pierre Cremieux is now Analysis Group’s CEO. Martha Samuelson, who was previously CEO and Chairman, will continue as Chairman and maintain her active consulting practice. https://t.co/Zq3Gzwz2wU
Applications to our first-ever Rise@AG Externship are open! Rise@AG is a week-long, case-shadowing program designed to introduce academically curious sophomores (class of 2024) from underrepresented backgrounds to the world of economic consulting. https://t.co/dbrUDiBvUN
1 / 7 Excited to announce new book with practical advice aimed at helping people think more analytically. Based on the wisdom of legendary @Harvard Professor Richard Zeckhauser #ThinkingAnalytically. 🧵
📘Paperback: https://t.co/5yaQO6zKzg
💻Ebook: https://t.co/YsD2GD9s1j
Beautifully written article (unfortunately so true) about French bureaucracy. France needs more data driven policies and less bureaucracy. via @NYTimes https://t.co/xyrtLlt4JW
Hydroxychloroquine & other drugs proposed for #COVID-19 treatments have had shortages.
We find news coverage contributes to shortages due to 1) hoarding by individuals & 2) stockpiling by institutions.
https://t.co/INtYsWqlTA
@maiamajumder@MaryalineC
@smanzi2 @Bos_CHIP
Applications for the #COVID19 Dispersed Volunteer Research Network [https://t.co/RCcSlQ97K2] are now live! With volunteers across disciplines, we've served as a virtual lab for 100+ researchers since March 2020. Retweet to get the word out & apply today: https://t.co/7mBYxe89J6
Relaxing #COVID19 social distancing too soon? What could happen? 1918 has some lessons for us. When schools and social gatherings commenced BEFORE we were at near zero cases, we got large secondary peaks. Let's not do this again. From: https://t.co/6WQcgluZ7A
En #France, face au #COVID19 deux mesures d’urgence sont nécessaires: plus de recherche (de qualité) en temps réel sur les bases de données existantes, et moins de bureaucratie. @DabWilliam @lemondefr @EmmanuelMacron @olivierveran https://t.co/q2Gi7kS2tB
« De la folie dans la folie, #COVID19 en #psychiatrie » alerte sur la situation des #soignants et des patients. Sans mesures urgentes et fortes, une situation similaire à celle des #EHPAD est à redouter très prochainement. #masques#tests#TestonsChezNous https://t.co/XmcrFgjxnj
@EmmanuelMacron@olivierveran@gouvernementFR Il n’est pas éthique avec les données scientifiques disponibles d’exiger des essais cliniques prolongés, ni de réserver les traitements prometteurs aux malades déjà en état grave. Ces délais tuent. Faites confiance à ceux qui savent.
Plusieurs Etats ont d'ores et déjà intégré l'hydroxychloroquine ou la chloroquine dans leurs recommandations thérapeutiques pour le traitement du Covid-19 dès la détection des symptômes du virus.